Dhillon explained this discrepancy by the possibility that they had discovered a rare phenomenon 42 or that the misalignment and imbalance of the p63 heterodimer may have altered the stability and function of p63, thereby disrupting cell cycle arrest and apoptosis and ultimately promoting prostate cancer progression. The gene discussed is TP63; the disease is prostate carcinoma.